Histone modifications in cocaine, methamphetamine and opioids

Histone modifications in cocaine, methamphetamine and opioids

Cocaine, methamphetamine and opioids are leading causes of drug abuse-related deaths worldwide. In recent decades, several studies revealed the connection between and epigenetics. Neural cells acquire epigenetic alterations that drive the onset and progress of the SUD by modifying the histone residu...

Full description

Bibliographic Details
Main Authors:	Junzhe Cheng, Ziping He, Qianqian Chen, Jiang Lin, Yilin Peng, Jinlong Zhang, Xisheng Yan, Jie Yan, Shuliang Niu
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Heliyon
Subjects:	Substance use disorder Histone modifications Cocaine Methamphetamine Opioids Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023036149

Similar Items

Potassium Channels and Their Potential Roles in Substance Use Disorders
by: Michael T. McCoy, et al.
Published: (2021-01-01)

Intentional use of both opioids and cocaine in the United States
by: Xiguang Liu, et al.
Published: (2023-06-01)

Current status and future prospects for the development of substance abuse vaccines
by: R. David Heekin, et al.
Published: (2017-11-01)

A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects
by: Celik M, et al.
Published: (2022-09-01)

Editorial: A Changing Epidemic and the Rise of Opioid-Stimulant Co-Use
by: Saeed Ahmed, et al.
Published: (2022-07-01)

Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant
by: Trecia A. Wouldes, et al.
Published: (2023-12-01)

Pharmacotherapy treatment of stimulant use disorder
by: Mei T. Liu, PharmD, BCPP
Published: (2021-11-01)

Effects of cocaine, methamphetamine and modafinil challenge on sleep rebound after paradoxical sleep deprivation in rats
by: R.C.S Martins, et al.
Published: (2008-01-01)

Study of Serum Malondialdehyde Level in Opioid and Methamphetamine Dependent Patients
by: Khadije Najafi, et al.
Published: (2017-12-01)

Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail
by: Hanis Mohammad Hazani, et al.
Published: (2022-04-01)

Associations between short-term ambient temperature exposure and emergency department visits for amphetamine, cocaine, and opioid use in California from 2005 to 2019
by: Howard H. Chang, et al.
Published: (2023-11-01)

Thirdhand smoke from tobacco, e-cigarettes, cannabis, methamphetamine and cocaine: Partitioning, reactive fate, and human exposure in indoor environments
by: Kristen Yeh, et al.
Published: (2022-02-01)

Cocaine Use Disorder (CUD): Current Clinical Perspectives
by: Schwartz EKC, et al.
Published: (2022-09-01)

The Relationship between Substance Use Stigma and COVID-19 Vaccine Hesitancy
by: Natasha Powell, et al.
Published: (2023-07-01)

Drugs of abuse in HIV infection and neurotoxicity
by: Melisa eHidalgo, et al.
Published: (2015-03-01)

Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates
by: Megan M. St. Peters, et al.
Published: (2023-03-01)

Does Prenatal Methamphetamine Exposure Induce Cross-sensitization to Cocaine and Morphine in Adult Male Rats?
by: Romana Šlamberová, et al.
Published: (2012-01-01)

Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016–2019
by: Riley D. Shearer, et al.
Published: (2024-03-01)

miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review
by: Carla Occhipinti, et al.
Published: (2023-12-01)

The distinct role of kappa opioid receptor in attenuating relapse to morphine/methamphetamine (polydrug) dependence in mice
by: Irna Elina Ridzwan, et al.
Published: (2018-07-01)

The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia
by: Jeff Ondocsin, et al.
Published: (2023-07-01)

The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
by: Madeline C. Frost, et al.
Published: (2021-10-01)

Modeling functional brain connections in methamphetamine and opioid abusers
by: Nasimeh Marvi, et al.
Published: (2024-03-01)

rTMS-Induced Changes in Glutamatergic and Dopaminergic Systems: Relevance to Cocaine and Methamphetamine Use Disorders
by: Jessica Moretti, et al.
Published: (2020-03-01)

Regulation of Garcinol on Histone Acetylation in the Amygdala and on the Reconsolidation of a Cocaine-Associated Memory
by: Melissa S. Monsey, et al.
Published: (2020-01-01)

Investigating the sequential patterns of methamphetamine use initiation in Iran
by: Ebrahim Moghimi Sarani, et al.
Published: (2020-07-01)

The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis
by: Richard A. Jenkins, et al.
Published: (2022-07-01)

Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
by: Claudia Calpe-López, et al.
Published: (2019-07-01)

A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder
by: Karla D. Wagner, et al.
Published: (2023-08-01)

Advantages of joint modeling of component HIV risk behaviors and non-response: application to randomized trials in cocaine-dependent and methamphetamine-dependent populations
by: Tyson H Holmes, et al.
Published: (2011-07-01)

Comparing Medical Comorbidities Between Opioid and Cocaine Users: A Data Mining Approach
by: Yong-Mi Kim
Published: (2019-12-01)

Dopamine Receptor D1 Contributes to Cocaine Epigenetic Reprogramming of Histone Modifications in Male Germ Cells
by: Betina González, et al.
Published: (2020-04-01)

Distinct and Dynamic Changes in the Temporal Profiles of Neurotransmitters in <i>Drosophila melanogaster</i> Brain following Volatilized Cocaine or Methamphetamine Administrations
by: Ana Filošević Vujnović, et al.
Published: (2023-10-01)

MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction
by: Bi Deng, et al.
Published: (2022-04-01)

Comparison of Personality Types and Alexithymia between Opiates Dependents, Concurrent Opiates and Methamphetamine Users and Control Group Referred to Drug Abuse Treatment Centers in Kerman City in 2020
by: F Heydari, et al.
Published: (2022-05-01)

Sex Differences in Substance Use Disorders: A Neurobiological Perspective
by: Jennifer L. Cornish, et al.
Published: (2021-12-01)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
by: Cayley Russell, et al.
Published: (2023-08-01)

Factors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users
by: Sercan Karabulut
Published: (2023-12-01)

Oxytocin, a Novel Treatment for Methamphetamine Use Disorder
by: Amber N. Edinoff, et al.
Published: (2022-01-01)

Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes
by: Richard Sherva, et al.
Published: (2021-02-01)